Eric Bates

1 week ago | businessinsider.com | Eric Bates |Adam Rogers |Henry Blodget

This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Have an account? . Marc Andreessen is, arguably, the most famous venture capitalist on earth.

1 week ago | businessinsider.com | Eric Bates |Aki Ito |Henry Blodget

This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Have an account? . In 2023, Kathleen, a sales manager at a software company, was given terrible news at work: She had to lay off her entire team. Her own job was spared, but surviving the bloodbath didn't leave her feeling relieved. "I felt like a traitor," she recalls. "I kept thinking, Oh, God, am I next?" After living in dread for months, she started looking for a new job.

3 weeks ago | businessinsider.com | Eric Bates |Adam Rogers |Henry Blodget

This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Have an account? . If Elon Musk's effort to remake the federal government was ever really about "waste, fraud, and abuse," those DOGE days are over. His quasi-agency has made huge and unprecedented changes to what the federal government does. But ask an economist, historian, or political scientist why, or what it all means, and you'll get a sad-sounding laugh in response.

1 month ago | businessinsider.com | Eric Bates |Adam Rogers |Henry Blodget

This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Have an account? . Americans angry about Elon Musk's unprecedented cuts to government services are voicing their displeasure at Tesla showrooms, and Musk isn't happy about it. "Who is funding and organizing all these paid protests?" he recently groused on X, referring to the ongoing wave of Tesla Takedown demonstrations taking place across the country.

Dec 6, 2024 | digitalcommons.library.tmc.edu | Johao Escobar |Mario Rodriguez |Eric Bates |Umair Khalid

AbstractDual antiplatelet therapy (DAPT) combines two antiplatelet agents to decrease the risk of thrombotic complications associated with atherosclerotic cardiovascular diseases. Emerging data about the duration of DAPT is being published continuously. New approaches are trying to balance the time, benefits, and risks for patients taking DAPT for established cardiovascular diseases.